Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples